Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Epidermal Growth Factor Receptor P753S Mutation in Cutaneous Squamous Cell Carcinoma Responsive to Cetuximab-Based Therapy.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology - 10 Feb 2016

Ganesan Prasanth, Ali Siraj M, Wang Kai, Blumenschein George R, Esmaeli Bita, Wolff Robert A, Miller Vincent A, Stephens Phillip J, Ross Jeffery S, Palmer Gary A, Janku Filip

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Antineoplastic Agents
Share to Carcinoma, Squamous Cell

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cetuximab

Share to ErbB Receptors

Share to Prognosis

Share to Skin Neoplasms

Share to Survival Rate

Source

Identifiers

PMID: 24934779
DOI: 10.1200/JCO.2013.50.3516

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 11 closest

Epidermal Growth Factor Receptor P753S Mutation in Cutaneous Squamous Cell Carcinoma Responsive to Cetuximab-Based Therapy.PMID 24934779Read ↗

First case of A859T epidermal growth factor receptor mutation responding to erlotinib.Semantic proximity Read ↗

Efficacy of a programmed death-1 checkpoint inhibitor in a case of cutaneous squamous cell carcinoma harboring mutations of TP53 and BRCA2.Semantic proximity Read ↗

RAS Mutations in Cutaneous Squamous-Cell Carcinomas in Patients Treated with BRAF InhibitorsSemantic proximity Read ↗

A sequential method of epidermal growth factor receptor mutation detection reduces false negatives: a new case with doublet mutations of L833V and H835L in China.Semantic proximity Read ↗

Acquired EGFR Resistance Mutation C797S in Pancreatic Adenocarcinoma Following Partial Response to Third-Generation EGFR Inhibitor Therapy.Semantic proximity Read ↗

Prevalence and clinical impact of Met Y1253D-activating point mutation in radiotherapy-treated squamous cell cancer of the oropharynxSemantic proximity Read ↗

Association of Oncogenic Mutations in Patients With Advanced Cutaneous Squamous Cell Carcinomas Treated With Cetuximab.Semantic proximity Read ↗

Activating Germline R776H Mutation in the Epidermal Growth Factor Receptor Associated With Lung Cancer With Squamous DifferentiationSemantic proximity Read ↗

A patient-derived somatic mutation in the epidermal growth factor receptor ligand-binding domain confers increased sensitivity to cetuximab in head and neck cancer.Semantic proximity Read ↗

Genetic variants of the EGFR ligand-binding domain and their association with structural alterations in Arab cancer patients.Semantic proximity Read ↗

Cetuximab Resistance in Head and Neck Cancer Is Mediated by EGFR-K521 Polymorphism.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.